Salicylic acid diminishes Staphylococcus aureus capsular polysaccharide type 5 expression

Infection and Immunity

Volumn 78, Issue 3, 2010, Pages 1339-1344

  Alvarez, Lucía P ^a   Barbagelata, María S ^a   Gordiola, Mariana ^a   Cheung, Ambrose L ^b   Sordelli, Daniel O ^a   Buzzola, Fernanda R ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE 5; SALICYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

BACTERIAL CAPSULES; BACTERIAL PROTEINS; CELL LINE; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALICYLIC ACID; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 77349118238     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00245-09     Document Type: Article

References (62)

1. Adhikari, R. P., and R. P. Novick. 2008. Regulatory organization of the staphylococcal sae locus. Microbiology 154:949-959.
2. Alvarez, L. P., M. S. Barbagelata, A. L. Cheung, D. O. Sordelli, and F. R. Buzzola. 2008. Abstr. XII Int. Cong. Bacteriol. Appl. Microbiol., abstr. BP-17.
3. Blickwede, M., R. Goethe, C. Wolz, P. Valentin-Weigand, and S. Schwarz. 2005. Molecular basis of florfenicol-induced increase in adherence of Staphylococcus aureus strain Newman. J. Antimicrob. Chemother. 56:315-323.
4. Buzzola, F. R., L. P. Alvarez, L. P. Tuchscherr, M. S. Barbagelata, S. M. Lattar, L. Calvinho, and D. O. Sordelli. 2007. Differential abilities of capsulated and noncapsulated Staphylococcus aureus isolates from diverse agr groups to invade mammary epithelial cells. Infect. Immun. 75:886-891.
5. Chen, Z., T. T. Luong, and C. Y. Lee. 2007. The sbcDC locus mediates repression of type 5 capsule production as part of the SOS response in Staphylococcus aureus. J. Bacteriol. 189:7343-7350.
6. Domenico, P., S. Schawartz, and B. A. Cunha. 1989. Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect. Immun. 57:3778-3782.
7. Domenico, P., D. R. Landolphi, and B. A. Cunha. 1991. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gramnegative bacteria by bismuth subsalicylate. J. Antimicrob. Chemother. 28: 801-810.
8. Duthie, E. S., and L. L. Lorenz. 1952. Staphylococcal coagulase: mode of action and antigenicity. J. Gen. Microbiol. 6:95-107.
9. Dziewanowska, K., A. R. Carson, J. M. Patti, C. F. Deobald, K. W. Bayles, and G. A. Bohach. 2000. Staphylococcal fibronectin binding protein interacts with heat shock protein 60 and integrins: role in internalization by epithelial cells. Infect. Immun. 68:6321-6328.
10. Farber, F. B., and R. C. Bone. 1992. The use of nonsteroidal anti-inflammatory drugs to prevent adherence of Staphylococcus epidermidis to medical polymers. J. Infect. Dis. 166:861-865.
11. Farthing, D., L. Gehr, T. H. Karnes, D. Sica, T. Gehr, T. Larus, C. Farthing, and L. Xi. 2007. Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse hearts. Biomarkers 12:623-634.
12. Garzoni, C., P. Francois, A. Huyghe, S. Couzinet, C. Tapparel, Y. Charbonnier, A. Renzoni, S. Lucchini, D. P. Lew, P. Vaudaux, W. L. Kelley, and J. Schrenzel. 2007. A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells. BMC Genomics 8:171.
13. Geiger, T., C. Goerke, M. Mainiero, D. Kraus, and C. Wolz. 2008. The virulence regulator Sae of Staphylococcus aureus: promoter activities and response to phagocytosis-related signals. J. Bacteriol. 190:3419-3428.
14. B in virulence gene expression during device-related infection. Infect. Immun. 73:3415-3421.
15. Grundmeier, M., M. Hussain, P. Becker, C. Heilmann, G. Peters, and B. Sinha. 2004. Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect. Immun. 72:7155-7163.
16. Gustafson, J. E., P. V. Candelaria, S. A. Fisher, J. P. Goodridge, T. M. Lichocik, T. M. McWilliams, C. T. D. Price, F. G. O'Brien, and W. B. Grubb. 1999. Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 43:990-992.
17. Herbert, S., S. W. Newell, C. Lee, K. P. Wieland, B. Dassy, J. M. Fournier, C. Wolz, and G. Döring. 2001. Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO2. J. Bacteriol. 183:4609-4613.
18. Hyunth, H., G. Robitaille, and J. D. Turner. 1991. Establishment of bovine mammary epithelial cells (MAC-T): an in vitro model for bovine lactation. Exp. Cell Res. 197:191-199.
19. Ingavale, S. S., W. van Wamel, and A. L. Cheung. 2003. Characterization of RAT, an autolysis regulator in Staphylococcus aureus. Mol. Microbiol. 48: 1451-1466.
20. Ingavale, S. S., W. van Wamel, T. T. Luang, C. Y. Lee, and A. L. Cheung. 2005. Rat/MgrA, a regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus. Infect. Immun. 73:1423-1431.
21. Karakawa, W. W., J. M. Fournier, W. F. Vann, R. Arbeit, R. S. Schneerson, and J. B. Robbins. 1985. Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. J. Clin. Microbiol. 22:445-447.
22. Kullik, I., P. Giachino, and T. Fuchs. 1998. Deletion of the alternative sigma factor sigmaB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180:4814-4820.
23. Kupferwasser, L. I., M. R. Yeaman, S. M. Shapiro, C. C. Nast, P. M. Sullam, S. G. Filler, and A. S. Bayer. 1999. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 99:2791-2797.
24. Kupferwasser, L. I., M. R. Yeaman, C. C. Nast, D. Kupferwasser, Y. Q. Xiong, M. Palma, A. L. Cheung, and A. S. Bayer. 2003. Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J. Clin. Invest. 112:222-233.
25. Lee, J. C., M. J. Liu, J. Parsonnet, and R. D. 1990. Expression of type-8 capsular polysaccharide and production of toxic shock syndrome toxin-1 are associated among vaginal isolates of Staphylococcus aureus. J. Clin. Microbiol. 28:2612-2615.
26. Lee, J. C., S. Takeda, P. J. Livolsi, and L. C. Paoletti. 1993. Effects of in vitro and in vivo growth conditions on expression of type-8 capsular polysaccharide by Staphylococcus aureus. Infect. Immun. 61:1853-1858.
27. Lee, C. Y., and J. C. Lee. 2006. Staphylococcal capsule, p. 456-463. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. ASM Press, Washington, DC.
28. Li, D., and A. L. Cheung. 2008. Repression of hla by rot is dependent on sae in Staphylococcus aureus. Infect. Immun. 76:1068-1075.
29. -ΔΔCT method. Methods 25:402-408.
30. Luong, T., S. Sau, M. Gomez, J. C. Lee, and C. Y. Lee. 2002. Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA. Infect. Immun. 70:444-450.
31. Luong, T. T., and C. Y. Lee. 2006. The arl locus positively regulates Staphylococcus aureus type 5 capsule via an mgrA-dependent pathway. Microbiology 152:3123-3131.
32. Ma, J., J. Cocchiaro, and J. C. Lee. 2004. Evaluation of serotypes of Staphylococcus aureus strains used in the production of a bovine mastitis bacterin. J. Dairy Sci. 87:178-182.
33. Manna, A., and A. L. Cheung. 2001. Characterization of sarR, a modulator of sar expression in Staphylococcus aureus. Infect. Immun. 69:885-896.
34. B-dependent arlRS and yabJ-spoVG loci affect capsule formation in Staphylococcus aureus. Infect. Immun. 75:4562-4571.
35. Moreillon, P., Y. I. Que, and M. P. Glauser. 2005. Staphylococcus aureus, p. 2321-2351. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious disease. Elsevier-Churchill Livingstone, Philadelphia, PA.
36. Muller, E., J. Al-Attar, A. G. Wolff, and B. F. Farber. 1998. Mechanism of salicylate-mediated inhibition of biofilm in Staphylococcus epidermidis. J. Infect. Dis. 177:501-503.
37. Needs, C. J., and P. M. Brooks. 1985. Clinical pharmacokinetics of the salicylates. Clin. Pharmacokinet. 10:164-177.
38. Novick, R. P. 1991. Genetic systems in staphylococci. Methods Enzymol. 204:587-636.
39. Novick, R. P., and D. Jiang. 2003. The staphylococcal saeRS system coordinates environmental signals with agr quorum sensing. Microbiology 149: 2709-2717.
40. O'Riordan, K., and J. C. Lee. 2004. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17:218-234.
41. Ouyang, S., S. Sau, and C. Y. Lee. 1999. Promoter analysis of the cap8 operon, involved in the type 8 capsular polysaccharide production in Staphylococcus aureus. J. Bacteriol. 181:2492-2500.
42. Palma, M., A. Bayer, L. I. Kupferwasser, T. Joska, M. R. Yeaman, and A. L. Cheung. 2006. Salicylic acid activates sigma factor B by rsbU-dependent and -independent mechanisms. J. Bacteriol. 188:5896-5903.
43. Park, W. B., S. H. Kim, J. H. Cho, J. H. Bang, H. B. Kim, N. J. Kim, M. D. Oh, and K. W. Choe. 2006. Effect of salicylic acid on invasion of human vascular endothelial cells by Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 49:56-61.
44. Price, C. T. D., F. G. O'Brien, B. P. Shelton, J. R. Warmington, W. B. Grubb, and J. E. Gustafson. 1999. Effects of salicylate and related compounds on fusidic acid MICs in Staphylococcus aureus. J. Antimicrob. Chemother. 44: 57-64.
45. Price, C. T. D., I. R. Lee, and J. E. Gustafson. 2000. The effects of salicylate on bacteria. Int. J. Biochem. Cell Biol. 32:1029-1043.
46. Price, C. T. D., and J. E. Gustafson. 2001. Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate. J. Med. Microbiol. 50:104-106.
47. Price, C. T. D., G. W. Kaatz, and J. E. Gustafson. 2002. The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus. Int. J. Antimicrob. Agents 20:212-219.
48. Prithiviraj, B., H. P. Bais, A. K. Jha, and J. M. Vivanco. 2005. Staphylococcus aureus pathogenicity on Arabidopsis thaliana is mediated either by a direct effect of salicylic acid on the pathogen or by SA-dependent, NPR1-independent host responses. Plant J. 42:417-432.
49. Riordan, J. T., A. Muthaiyan, W. van Borréis, C. T. Price, J. E. Gram, B. J. Wilkinson, and J. E. Gustafson. 2007. Response of Staphylococcus aureus to salicylate challenge. J. Bacteriol. 189:220-227.
50. Rogasch, K., V. Rühmling, J. Pané-Farré, D. Höper, C. Weinberg, S. Fuchs, M. Schmudde, B. M. Bröker, C. Wolz, M. Hecker, and S. Engelmann. 2006. Influence of the two-component system saeRS on global gene expression in two different Staphylococcus aureus strains. J. Bacteriol. 188:7742-7758.
51. Sau, S., J. Sun, and C. Y. Lee. 1997. Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus. J. Bacteriol. 179:1614-1621.
52. Seidl, K., M. Stucki, M. Ruegg, C. Goerke, C. Wolz, L. Harris, B. Berger-Bächi, and M. Bischoff. 2006. Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance. Antimicrob. Agents Chemother. 50:1183-1194.
53. Sinha, B., P. P. François, O. Nüsse, M. Foti, O. M. Hartford, P. Vaudaux, T. J. Foster, D. P. Lew, M. Herrmann, and K. H. Krause. 1999. Fibronectinbinding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin 5 1. Cell. Microbiol. 1:101-117.
54. Sinha, B., and M. Herrmann. 2005. Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus. Thromb. Haemost. 94: 266-277.
55. Steinhuber, A., C. Goerke, M. G. Bayer, G. Doring, and C. Wolz. 2003. Molecular architecture of the regulatory locus sae of Staphylococcus aureus and its impact on expression of virulence factors. J. Bacteriol. 185:6278-6286.
56. Tollersrud, T., K. Kenny, A. J. Reitz, and J. C. Lee. 2000. Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States. J. Clin. Microbiol. 38:2998-3003.
57. Tuchscherr, L. P. N., F. R. Buzzola, L. P. Alvarez, R. Caccuri, J. C. Lee, and D. O. Sordelli. 2005. Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice. Infect. Immun. 73:7932-7937.
58. Vane, J. R., and R. M. Botting. 1992. The history of aspirin, p. 3-34. In J. R. Vane and R. M. Botting (ed.), Aspirin and other salicylates. Chapman and Hall, London, United Kingdom.
59. van Wamel, W., Y. Q. Xiong, A. S. Bayer, M. R. Yeaman, C. C. Nast, and A. L. Cheung. 2002. Regulation of Staphylococcus aureus type 5 capsular polysaccharides by agr and sarA in vitro and in an experimental endocarditis model. Microb. Pathog. 33:73-79.
60. von Eiff, C., G. Peters, and K. Becker. 2006. The small colony variant (SCV) concept - the role of staphylococcal SCVs in persistent infections. Injury 37(Suppl. 2):S26-S33.
61. Wann, E. R., B. Dassy, J. M. Fournier, and T. J. Foster. 1999. Genetic analysis of the cap5 locus of Staphylococcus aureus. FEMS Microbiol. Lett. 170:97-103.
62. Watts, J. A., D. Ke, Q. Wang, A. Pillay, A. Nicholson-Weller, and J. C. Lee. 2005. Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence. Infect. Immun. 73:3502-3511.